- Home
- NIVF vs BDRX Comparison
NIVF vs BDRX Comparison
Compare NIVF & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIVF
- BDRX
- Stock Information
- Founded
- NIVF 2011
- BDRX 2000
- Country
- NIVF Thailand
- BDRX United Kingdom
- Employees
- NIVF N/A
- BDRX N/A
- Industry
- NIVF
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- NIVF
- BDRX Health Care
- Exchange
- NIVF NYSE
- BDRX Nasdaq
- Market Cap
- NIVF 12.2M
- BDRX 2.8M
- IPO Year
- NIVF N/A
- BDRX N/A
- Fundamental
- Price
- NIVF $1.16
- BDRX $6.15
- Analyst Decision
- NIVF
- BDRX Strong Buy
- Analyst Count
- NIVF 0
- BDRX 1
- Target Price
- NIVF N/A
- BDRX $200.00
- AVG Volume (30 Days)
- NIVF 11.9M
- BDRX 457.8K
- Earning Date
- NIVF 11-16-2024
- BDRX 10-29-2024
- Dividend Yield
- NIVF N/A
- BDRX N/A
- EPS Growth
- NIVF N/A
- BDRX N/A
- EPS
- NIVF 0.21
- BDRX N/A
- Revenue
- NIVF $5,136,153.00
- BDRX $104,895.00
- Revenue This Year
- NIVF N/A
- BDRX N/A
- Revenue Next Year
- NIVF N/A
- BDRX N/A
- P/E Ratio
- NIVF $5.39
- BDRX N/A
- Revenue Growth
- NIVF N/A
- BDRX N/A
- 52 Week Low
- NIVF $0.55
- BDRX $4.71
- 52 Week High
- NIVF $17.24
- BDRX $220.25
- Technical
- Relative Strength Index (RSI)
- NIVF 56.42
- BDRX 43.80
- Support Level
- NIVF $1.07
- BDRX $5.50
- Resistance Level
- NIVF $3.28
- BDRX $10.89
- Average True Range (ATR)
- NIVF 0.42
- BDRX 1.07
- MACD
- NIVF 0.05
- BDRX 0.32
- Stochastic Oscillator
- NIVF 22.42
- BDRX 23.30
About NIVF NEWGENIVF GROUP LIMITED
NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.
About BDRX Biodexa Pharmaceuticals plc American Depositary Shs
Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.